Addition of Clopidogrel to Aspirin in 45852 Patients With Acute Myocardial Infarction: Randomised Placebo-Controlled Trial
Lancet 366:1607-1621, COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group, 2005

Dipyridamole for Preventing Recurrent Ischemic Stroke and Other Vascular Events
Stroke 36:162-168, Leonardi-Bee,J.,et al, 2005

Expanding Indications for Statins in Cerebral Ischemia
Arch Neurol 62:67-72,23, Ovbiagele,B.,et al, 2005

Homocysteine and Stroke: Evidence on a Causal Link From Mendelian Randomisation
Lancet 365:224-232, 194, Casas, J.P., et al, 2005

Efficacy of Aspirin Plus Extended-Release Dipyridamole in Preventing Recurrent Stroke in High-Risk Populations
Arch Neurol 62:403-408, Sacco, R.L., et al, 2005

Timing of TIAs Preceding Stroke
Neurol 64:817-820, Rothwell, P.M. & Warlow, C.P., 2005

Blood Pressure Control and Risk of Stroke
Stroke 36:725-730, Li,C.,et al, 2005

Anticoagulants Versus Antiplatelet Therapy for Preventing Stroke in Patients with Nonrheumatic ATrial Fibrillation and a History of Stroke or Transient Ischemic Attack
Stroke 36:914-915, Saxena,R. &Koudstaal,P.J., 2005

Adding Aspirin to Clopidogrel After TIA and Ischemic Stroke
Neurol 64:1117-1121, Hankey,G.J. &Eikelboom,J.W., 2005

Ximelagatran--Promises and Concerns
JAMA 293:736-739, Gurewich,V., 2005

Ximelagatran vs Warfarin for Stroke Prevention in Patients with Nonvalvular Atrial Fibrillation
JAMA 293:690-698,736, SPORTIF Executive Steering Committee for the SPORTIF V Investigators, 2005

Costs and Effectiveness of Ximelagatran for Stroke Prophylaxis in Chronic Atrial Fibrillation
JAMA 293:699-706, OBrien,C.L. &Gage,B.F., 2005

Influenza Vaccination is Associated with a Reduced Risk of Stroke
Stroke 36:1501-1506, Grau,A.J.,et al, 2005

A Simple Score (ABCD) to Identify Individuals at High Early Risk of Stroke After Transient Ischaemic Attack
Lancet 366:29-36, Rothwell,P.M.,et al, 2005

Major Risk Factors for Intracerebral Hemorrhage in the Young Are Modifiable
Stroke 36:1881-1885, Feldmann,E.,et al, 2005

Efficacy and Safety of Cholesterol-Lowering Treatment: Prospective Meta-Analysis of Data from 90056 Participants in 14 Randomised Trials of Statins
Lancet 366:1267-1278, Cholesterol Treatment Trialists (CTT) Collaborators, 2005

In-Hospital Initiation of Secondary Stroke Prevention Therapies Yields High Rates of Adherence at Follow-up
Stroke 35:2879-2883, Ovbiagele,B.,et al, 2004

Statins in Stroke Prevention and Carotid Artherosclerosis, Systematic Review and Up-to-Date Meta-Analysis
Stroke 35:2902-2909, Amarenco,P.,et al, 2004

Lowering Homocysteine in Patients with Ischemic Stroke to Prevent Recurrent Stroke, Myocardial Infarction, and Death
JAMA 291:565-575,621, Toole,J.F.,et al, 2004

Benefit of Clopidogrel Over Aspirin is Amplified in Patients with a History of Ischemic Events
Stroke 35:528-532, Ringleb,P.A.,et al, 2004

Population Based Study of Early Risk of Stroke after Transient Ischaemic Attack or Minor Stroke:Implications for Public Education and Organisation of Services
BMJ 328:326-328,297, Coull,A.J.,et al, 2004

Blood Pressure and Stroke
Stroke 35:776-785, Lawes,C.M.M.,et al, 2004

Patent Foramen Ovale and Recurrent Stroke: Closure is the Best Option: No
Stroke 35:804-805,806, Tong,D.C. &Becker,K.J., 2004

Patent Foramen Ovale and Recurrent Stroke: Closure is the Best Option: Yes
Stroke 35:803-804,806, Furlan,A.J., 2004

Endarterectomy for Symptomatic Carotid Stenosis in Relation to Clinical Subgroups and Timing of Surgery
Lancet 363:915-924, Rothwell,P.M.,et al, 2004

Effects of Cholesterol-lowering with Simvastatin on Stroke and Other Major Vascular Events in 20 536 People with Cerebrovascular Disease or Other High-Risk Conditions
Lancet 363:757-767, Heart Protection Study Collaborative Group, 2004

Prevention of Disabling and Fatal Strokes by Successful Carotid Endarterectomy in Patients Without Recent Neurological Symptoms: Randomised Controlled Trial
Lancet 363:1491-1502,1486, MRC Asymptomatic Carotid Surgery Trial (ACST) Coll, 2004

Prescription of Antithrombotic Therapy in Older Patients Hospitalized for Transient Ischemic Attack and Ischemic Stroke:The GIFA Study
Stroke 35:913-917, Volpato,S.,et al, 2004

Antiplatelet Therapy for Preventing Stroke and Other Vascular Events After Carotid Endarterectomy
Stroke 35:1227-1228, Engelter,S. &Lyrer,P., 2004

Favorable Outcome of Ischemic Stroke in Patients Pretreated with Statins
Stroke 35:1117-1123, Marti-Fabregas,J.,et al, 2004

Practice Parameter: Recurrent Stroke with Patent Foramen Ovale and Atrial Septal Aneurysm
Neurol 62:1042-1050, Messe,S.R.,et al, 2004

Direct Thrombin Inhibition
Stroke 35:1519-1522, Elkind,M.S.V. &Sacco,R.L., 2004

Aspriin and Clopidogrel Compared with Colpidogrel Alone After Recent Ischaemic Stroke or Transient Ischaemic Attack in High-Risk Patients (MATCH): Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 364:331-337, Diener,H.-C.,et al, 2004

Anticoagulants for Preventing Stroke in Patients with Nonrheumatic Atrial Fibrillation and a History of Stroke or Transient Ischemic Attack
Stroke 35:1782-1783, Saxena,R. &Koudstaal,P.J., 2004

Fish Consumption and Incidence of Stroke
Stroke 35:1538-1542, He,K.,et al, 2004

PROTECT A Coordinated Stroke Treatment Program to Prevent Recurrent Thromboembolic Events
Neurol 63:1217-1222, Ovbiagele,B.,et al, 2004

Thoughts Evoked by MATCH and Other Trials
Stroke 35:2604-2605, Caplan,L.R., 2004

The MATCH Study Results in the Context of Secondary Stroke Prevention
Stroke 35:2609, Fisher,M. &Davalos,A., 2004

Physical Activity and Stroke Risk
Stroke 34:2475-2482, Lee,C.D.,et al, 2003

Dietary Antioxidants and the Risk of Ischemic Stroke
Neurol 61:1273-1275, Voko,Z.,et al, 2003

A 50-Year-Old Woman With Atrial Fibrillation
JAMA 290:2182-2189, Singer,D.E., 2003

Hyperhomocysteinemia as an Independent Risk Factor for Silent Brain Infarction
Neurol 61:1595-1599, Kim,N.K.,et al, 2003

Stroke Prevention with the Oral Direct Thrombin Inhibitor Ximelagatran Compared with Warfarin in Patients with Non-Valvular Atrial Fibrillation (SPORTIF III): Randomised Controlled Trial
Lancet 362:1691-1698,1686, Executive Steering Committee on Behalf of the SPOR, 2003

10 Most Commonly Asked Questions About Which Antiplatelet Agent to Prescribe
The Neurologist 9:318-322, Adams,H.P. Jr., 2003

Determination of Lipid Profiles and Use of Statins in Patients With Ischemic Stroke or Transient Ischemic Attack
Stroke 34:105-110, Lalouschek,W.,et al, 2003

Trends in Community Knowledge of the Warning Signs and Risk Factors for Stroke
JAMA 289:343-346, Schneider,A.T.,et al, 2003

Risk of Stroke Associated With Nonsteroidal Anti-Inflammatory Drugs
Stroke 34:379-386, Bak,S.,et al, 2003

Oral Anticoagulants Versus Antiplatelet Therapy for Preventing Further Vascular Events After Transient Ischemic Attack or Minor Stroke of Presumed Arterial Origin
Stroke 34:234-235, Algra,A.,et al, 2003

Platelet Function Under Aspirin, Clopidogrel, and Both After Ischemic Stroke
Stroke 34:849-855, Grau,A.J.,et al, 2003

Secondary Prevention of Stroke in Italy
Stroke 34:1010-1014, Filippi,A.,et al, 2003